Drugplain

Neomycin and Polymyxin B Sulfates and Bacitracin Zinc 400 [USP'U]/g

Neomycin sulfate, Polymyxin B Sulfate and Bacitracin Zinc · OINTMENT · Bausch & Lomb Incorporated

No Recall History
Plain English

This is an antibiotic ointment applied directly to the eye that contains three different antibiotics to help treat or prevent bacterial eye infections. It works by killing bacteria that cause infections on the eye surface.

Key Facts

Brand Name
Neomycin and Polymyxin B Sulfates and Bacitracin Zinc
Generic Name
Neomycin sulfate, Polymyxin B Sulfate and Bacitracin Zinc
NDC Code (Product)
24208-780
Manufacturer
Bausch & Lomb Incorporated
Strength
400 [USP'U]/g
Dosage Form
OINTMENT
Route
OPHTHALMIC
Marketing Status
Application #
ANDA064064
Marketing Start
10/30/1995

Recall History

No Recall History

Frequently Asked Questions

What is Neomycin and Polymyxin B Sulfates and Bacitracin Zinc used for?

This is an antibiotic ointment applied directly to the eye that contains three different antibiotics to help treat or prevent bacterial eye infections. It works by killing bacteria that cause infections on the eye surface.

Is Neomycin and Polymyxin B Sulfates and Bacitracin Zinc a controlled substance?

Neomycin and Polymyxin B Sulfates and Bacitracin Zinc is not classified as a controlled substance by the DEA.

What is the generic name for Neomycin and Polymyxin B Sulfates and Bacitracin Zinc?

The generic name for Neomycin and Polymyxin B Sulfates and Bacitracin Zinc is Neomycin sulfate, Polymyxin B Sulfate and Bacitracin Zinc. There are no other listed brand versions of Neomycin sulfate, Polymyxin B Sulfate and Bacitracin Zinc.

What is the NDC code for Neomycin and Polymyxin B Sulfates and Bacitracin Zinc 400 [USP'U]/g?

The NDC (National Drug Code) for Neomycin and Polymyxin B Sulfates and Bacitracin Zinc 400 [USP'U]/g is 24208-780, listed by Bausch & Lomb Incorporated.

Product NDC

24208-780

Package NDC

24208-780-55

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)